SamanTree Medical key facts
as of Oct 2026- Developer of medical imaging devices designed to improve cancer treatment care.
- SamanTree Medical is valued at approximately $66.3M as of Oct 2026 (last reported valuation).
- It has raised $50.4M; the latest was Debt - General ($23.4M) in Jan 2026.
- Notable investors include Venture Kick, b2venture, Venture (Switzerland), Brabantse Ontwikkelings Maatschappij, XAnge — 16 tracked in total.
- Status: Privately Held (backing).
SamanTree Medical's last reported valuation, Jul 2024. Nothing priced has surfaced since.
- ·The complete investor list: 16 names
- ·Watch SamanTree Medical: the Monday email on marks, rounds and moves
SamanTree Medical funding rounds
No funding rounds for SamanTree Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs SamanTree Medical
16+Membership and data by Private Market View
SamanTree Medical valuation
SamanTree Medical's last reported valuation was $66.3 million in Jul 2024. No priced round, secondary trade or fund mark has surfaced since.
SamanTree Medical investors
16 investors are on record for SamanTree Medical, including Venture Kick, b2venture, Venture (Switzerland) and Brabantse Ontwikkelings Maatschappij.
About SamanTree Medical
Developer of medical imaging devices designed to improve cancer treatment care. The company's devices enable a global mapping of a lumpectomy for full margin control with histology-grade confidence before closing the incision, enabling clinicians to visualize cancerous cells on a surgical specimen during surgery.
- Sector
- Healthcare
- HQ
- Awans, Belgium
- Founded
- 2014
- Employees
- 48
- Website
- samantree.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.